Monday, December 9, 2024

CATEGORY

Dermapharm

Roche Submits Columvi plus GemOx for FDA Approval in Aggressive Lymphoma

Key TakeawaysColumvi plus GemOx demonstrated a statistically significant and clinically meaningful improvement in overall survival. The fixed-duration treatment offers a timely option post-diagnosis...

Boehringer Ingelheim Introduces VETMEDIN® Solution: A New Option for Canine Heart Disease

Key TakeawaysBoehringer Ingelheim launches VETMEDIN® Solution, the first FDA-approved oral liquid for congestive heart failure in dogs. This innovative solution addresses heart disease...

FDA Launches Urgent Review on Adult Prescription Stimulant Abuse

The U.S. Food and Drug Administration has initiated a swift evaluation to address the rising misuse of ADHD prescription stimulants among adults. This comprehensive...

FDA Implements New Sterilization Policy, Approves Life-Saving Drug, and Expands Carrot E. coli Recall

The U.S. Food and Drug Administration announced several significant updates today, addressing sterilization policies, drug approvals, and food safety measures to safeguard public health.   New...

Latest news